Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Organ Transplant Anti-rejection Medications market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Organ Transplant Anti-rejection Medicationsmarket, defines the market attractiveness level of Organ Transplant Anti-rejection Medications market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Organ Transplant Anti-rejection Medications industry, describes the types of Organ Transplant Anti-rejection Medications market, the applications of major players and the market size, and deeply analyzes the current situation of the global Organ Transplant Anti-rejection Medications market and the development prospects and opportunities of Organ Transplant Anti-rejection Medications industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Organ Transplant Anti-rejection Medications market in Chapter 13.
By Player:
Roche
Astellas Pharma Inc
AbbVie Inc
GSK
Bristol-Myers Squibb Company (BMS)
Pfizer
Novartis AG
Allergan plc
Sanofi
By Type:
Kidney Transplant Anti-rejection Medications
Bone Marrow Transplant Anti-rejection Medications
Liver Transplant Anti-rejection Medications
Heart Transplant Anti-rejection Medications
Lung Transplant Anti-rejection Medications
Other
By End-User:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Organ Transplant Anti-rejection Medications Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Organ Transplant Anti-rejection Medications Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Organ Transplant Anti-rejection Medications Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Organ Transplant Anti-rejection Medications Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Organ Transplant Anti-rejection Medications Market Analysis and Outlook to 2022
-
7.1 Global Organ Transplant Anti-rejection Medications Consumption (2017-2022)
-
7.2 United States Organ Transplant Anti-rejection Medications Consumption (2017-2022)
-
7.3 Europe Organ Transplant Anti-rejection Medications Consumption (2017-2022)
-
7.4 China Organ Transplant Anti-rejection Medications Consumption (2017-2022)
-
7.5 Japan Organ Transplant Anti-rejection Medications Consumption (2017-2022)
-
7.6 India Organ Transplant Anti-rejection Medications Consumption (2017-2022)
-
7.7 South Korea Organ Transplant Anti-rejection Medications Consumption (2017-2022)
8 Region and Country-wise Organ Transplant Anti-rejection Medications Market Analysis and Outlook to 2028
-
8.1 Global Organ Transplant Anti-rejection Medications Consumption Forecast (2022-2028)
-
8.2 United States Organ Transplant Anti-rejection Medications Consumption Forecast (2022-2028)
-
8.3 Europe Organ Transplant Anti-rejection Medications Consumption Forecast (2022-2028)
-
8.4 China Organ Transplant Anti-rejection Medications Consumption Forecast (2022-2028)
-
8.5 Japan Organ Transplant Anti-rejection Medications Consumption Forecast (2022-2028)
-
8.6 India Organ Transplant Anti-rejection Medications Consumption Forecast (2022-2028)
-
8.7 South Korea Organ Transplant Anti-rejection Medications Consumption Forecast (2022-2028)
9 Global Organ Transplant Anti-rejection Medications Market Outlook by Types and Applications to 2022
-
9.1 Global Organ Transplant Anti-rejection Medications Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Kidney Transplant Anti-rejection Medications Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Bone Marrow Transplant Anti-rejection Medications Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Liver Transplant Anti-rejection Medications Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Heart Transplant Anti-rejection Medications Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Lung Transplant Anti-rejection Medications Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Organ Transplant Anti-rejection Medications Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Organ Transplant Anti-rejection Medications Market Outlook by Types and Applications to 2028
-
10.1 Global Organ Transplant Anti-rejection Medications Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Kidney Transplant Anti-rejection Medications Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Bone Marrow Transplant Anti-rejection Medications Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Liver Transplant Anti-rejection Medications Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Heart Transplant Anti-rejection Medications Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Lung Transplant Anti-rejection Medications Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Organ Transplant Anti-rejection Medications Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Organ Transplant Anti-rejection Medications Import and Export Analysis (Top 5 Countries)
-
11.1 Global Organ Transplant Anti-rejection Medications Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Organ Transplant Anti-rejection Medications Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Organ Transplant Anti-rejection Medications Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Organ Transplant Anti-rejection Medications Market Competitive Analysis
-
14.1 Roche
-
14.1.1 Roche Company Details
-
14.1.2 Roche Organ Transplant Anti-rejection Medications Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Roche Organ Transplant Anti-rejection Medications Product and Service
-
14.2 Astellas Pharma Inc
-
14.2.1 Astellas Pharma Inc Company Details
-
14.2.2 Astellas Pharma Inc Organ Transplant Anti-rejection Medications Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Astellas Pharma Inc Organ Transplant Anti-rejection Medications Product and Service
-
14.3 AbbVie Inc
-
14.3.1 AbbVie Inc Company Details
-
14.3.2 AbbVie Inc Organ Transplant Anti-rejection Medications Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AbbVie Inc Organ Transplant Anti-rejection Medications Product and Service
-
14.4 GSK
-
14.4.1 GSK Company Details
-
14.4.2 GSK Organ Transplant Anti-rejection Medications Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GSK Organ Transplant Anti-rejection Medications Product and Service
-
14.5 Bristol-Myers Squibb Company (BMS)
-
14.5.1 Bristol-Myers Squibb Company (BMS) Company Details
-
14.5.2 Bristol-Myers Squibb Company (BMS) Organ Transplant Anti-rejection Medications Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bristol-Myers Squibb Company (BMS) Organ Transplant Anti-rejection Medications Product and Service
-
14.6 Pfizer
-
14.6.1 Pfizer Company Details
-
14.6.2 Pfizer Organ Transplant Anti-rejection Medications Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Organ Transplant Anti-rejection Medications Product and Service
-
14.7 Novartis AG
-
14.7.1 Novartis AG Company Details
-
14.7.2 Novartis AG Organ Transplant Anti-rejection Medications Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis AG Organ Transplant Anti-rejection Medications Product and Service
-
14.8 Allergan plc
-
14.8.1 Allergan plc Company Details
-
14.8.2 Allergan plc Organ Transplant Anti-rejection Medications Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Allergan plc Organ Transplant Anti-rejection Medications Product and Service
-
14.9 Sanofi
-
14.9.1 Sanofi Company Details
-
14.9.2 Sanofi Organ Transplant Anti-rejection Medications Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Sanofi Organ Transplant Anti-rejection Medications Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Organ Transplant Anti-rejection Medications
-
Figure Organ Transplant Anti-rejection Medications Picture
-
Table Global Organ Transplant Anti-rejection Medications Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Organ Transplant Anti-rejection Medications Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Organ Transplant Anti-rejection Medications Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Organ Transplant Anti-rejection Medications Consumption by Country (2017-2022)
-
Figure United States Organ Transplant Anti-rejection Medications Consumption and Growth Rate (2017-2022)
-
Table Europe Organ Transplant Anti-rejection Medications Consumption and Growth Rate (2017-2022)
-
Figure China Organ Transplant Anti-rejection Medications Consumption and Growth Rate (2017-2022)
-
Figure Japan Organ Transplant Anti-rejection Medications Consumption and Growth Rate (2017-2022)
-
Figure India Organ Transplant Anti-rejection Medications Consumption and Growth Rate (2017-2022)
-
Figure South Korea Organ Transplant Anti-rejection Medications Consumption and Growth Rate (2017-2022)
-
Figure Global Organ Transplant Anti-rejection Medications Consumption Forecast by Country (2022-2028)
-
Figure United States Organ Transplant Anti-rejection Medications Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Organ Transplant Anti-rejection Medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Organ Transplant Anti-rejection Medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Organ Transplant Anti-rejection Medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Organ Transplant Anti-rejection Medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Organ Transplant Anti-rejection Medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney Transplant Anti-rejection Medications Consumption and Growth Rate (2017-2022)
-
Figure Global Bone Marrow Transplant Anti-rejection Medications Consumption and Growth Rate (2017-2022)
-
Figure Global Liver Transplant Anti-rejection Medications Consumption and Growth Rate (2017-2022)
-
Figure Global Heart Transplant Anti-rejection Medications Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Transplant Anti-rejection Medications Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Transplant Anti-rejection Medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bone Marrow Transplant Anti-rejection Medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liver Transplant Anti-rejection Medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Heart Transplant Anti-rejection Medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Transplant Anti-rejection Medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Organ Transplant Anti-rejection Medications Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Organ Transplant Anti-rejection Medications Export by Region (Top 5 Countries) (2017-2028)
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Organ Transplant Anti-rejection Medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Organ Transplant Anti-rejection Medications Product and Service
-
Table Astellas Pharma Inc (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Inc Organ Transplant Anti-rejection Medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Inc Organ Transplant Anti-rejection Medications Product and Service
-
Table AbbVie Inc (Foundation Year, Company Profile and etc.)
-
Table AbbVie Inc Organ Transplant Anti-rejection Medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Inc Organ Transplant Anti-rejection Medications Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Organ Transplant Anti-rejection Medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Organ Transplant Anti-rejection Medications Product and Service
-
Table Bristol-Myers Squibb Company (BMS) (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company (BMS) Organ Transplant Anti-rejection Medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company (BMS) Organ Transplant Anti-rejection Medications Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Organ Transplant Anti-rejection Medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Organ Transplant Anti-rejection Medications Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Organ Transplant Anti-rejection Medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Organ Transplant Anti-rejection Medications Product and Service
-
Table Allergan plc (Foundation Year, Company Profile and etc.)
-
Table Allergan plc Organ Transplant Anti-rejection Medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan plc Organ Transplant Anti-rejection Medications Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Organ Transplant Anti-rejection Medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Organ Transplant Anti-rejection Medications Product and Service
-
